ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.726,76
-0,21%
S&P 500
5.321,41
0,25%
Dow Jones
39.872,99
0,17%
Euro vs US Dollar
1,08602
0,05%
Bitcoin
70.211,58
0,11%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Hollis-Eden Pharmaceuticals (MM) (HEPH)

  7. Hollis-Eden Pharmaceuticals (MM) (HEPH) News

HEPH

Hollis-Eden Pharmaceuticals (MM) (HEPH)

Hollis-Eden Pharmaceuticals (MM)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:HEPH
DatumZeitQuelleÜberschriftSymbolFirma
17/02/201022h03PR Newswire (US)Hollis-Eden Announces Name Change to Harbor BioSciences, Inc. and Ticker Symbol Change to 'HRBR'NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
16/02/201022h27Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
03/02/201020h39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
03/02/201020h38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
03/02/201020h37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
03/02/201020h37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
03/02/201020h36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
03/02/201020h35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
03/02/201020h35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
06/01/201022h31Edgar (US Regulatory)Securities Registration Statement (simplified form) (S-3/A)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
22/12/200922h38Edgar (US Regulatory)Securities Registration Statement (simplified form) (S-3)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
15/12/200912h03Edgar (US Regulatory)Securities Registration (section 12(b)) (8-A12B)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
16/11/200915h00PR Newswire (US)Hollis-Eden Presents New Interim Data From Prostate Cancer Phase I/II Clinical Studies of Apoptone (HE3235) at AACR Molecular TaNASDAQ:HEPH
12/11/200922h37PR Newswire (US)Hollis-Eden to Present Interim Data From Its Phase I/II Clinical Studies of Apoptone(R) (HE3235) at Molecular Targets and CancerNASDAQ:HEPH
06/11/200923h23Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
22/10/200912h05Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
20/10/200915h11PR Newswire (US)Hollis-Eden Pharmaceuticals Retains Burrill LLC to Provide Exclusive Advisory Services for Lead ProgramsNASDAQ:HEPH
16/09/200919h33Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
16/09/200914h30PR Newswire (US)Hollis-Eden Pharmaceuticals Receives NASDAQ Notification Related to Minimum Bid PriceNASDAQ:HEPH
14/08/200912h06Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
15/06/200921h52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
15/06/200918h30Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
15/06/200913h05PR Newswire (US)Hollis-Eden Pharmaceuticals Announces Appointment of Dr. James M. Frincke President and CEONASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
11/06/200922h54Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
05/06/200922h06Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
14/05/200912h03Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
07/05/200923h00Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
23/04/200923h00Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
31/03/200923h36Business WireHollis-Eden Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial ResultsNASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
31/03/200923h30Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:HEPH

Kürzlich von Ihnen besucht

BSTP
XLMGBP
Stellar Lumens
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten